Adult-onset Still's disease (AOSD) is an uncommon inflammatory condition characterised by high fever, leukocytosis with neutrophilia, arthralgia and skin rash. Diagnosis is often clinical, and it is always necessary to exclude common disease mimics such as infections, malignancies and other rheumatic diseases. Ferritin and glycosylated ferritin are useful adjuncts to aid in the diagnosis of AOSD. Important complications to consider include fulminant hepatitis, disseminated intravascular coagulopathy and hemophagocytic syndrome. Mainstay treatment of AOSD is often with glucocorticoids. Other agents that can also be used include methotrexate, and biologic therapy, such as tumor necrosis factor-α (TNF-α) blockers and interleukin-1 (IL-1) inhibitors. A retrospective review of patients diagnosed with AOSD admitted to Singapore General Hospital (SGH) was performed, and their disease characteristics and laboratory findings were compared with that of previous published cohorts.
StillGF. On a form of chronic joint disease in children. Arch Dis Child1941;16(87):156–65.
2.
BywatersEG. Still's disease in the adult. Ann Rheum Dis1971;30(2):121–33.
3.
van de PutteLBWoutersJM. Adult-onset Still's disease. Baillieres Clin Rheumatol1991;5(2):263–75.
4.
MassonCLeLXLiotéFRenouPDubostJJBoissierMC. Adult Still's disease: Part I. Manifestations and complications in sixty-five cases in France. Rev Rhum Engl Ed1995;62(11):748–57.
5.
PouchotJSampalisJSBeaudetFCaretteSDécaryFSalusinsky-SternbachM. Adult Still's disease: Manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore)1991;70(2):118–36.
6.
TerkeltaubREsdaileJMDécaryFHarthMListerJLapointeN. HLA-Bw35 and prognosis in adult Still's disease. Arthritis Rheum1981;24(12):1469–72.
7.
JoungCIJunJBChungWTSongGGChoeJYChangHK. Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol2006;35(1):39–43.
8.
FujiiTNojimaTYasuokaHSatohSNakamuraKKuwanaM. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford)2001;40(12):1398–404.
9.
FautrelB. Adult-onset Still disease. Best Pract Res Clin Rheumatol2008;22(5):773–92.
10.
ChenDYLanJLLinFJHsiehTYWenMC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis2004;63(10):1300–6.
11.
ChenDYChenYMLanJLLinCCChenHHHsiehCW. Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease. Rheumatology (Oxford)2010;49(12):2305–12.
12.
HoshinoTOhtaANakaoMOtaTInokuchiTMatsuedaS. TCR gamma delta + T cells in peripheral blood of patients with adult Still's disease. J Rheumatol1996;23(1):124–9.
13.
ChenDYChenYMChenHHHsiehCWLinCCLanJL. The associations of circulating CD4+CD25high regulatory T cells and TGF-β with disease activity and clinical course in patients with adult-onset Still's disease. Connect Tissue Res2010;51(5):370–7.
14.
ChenDYLanJLLinFJHsiehTY. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease. J Rheumatol2004;31(11):2189–98.
15.
PascualVAllantazFArceEPunaroMBanchereauJ. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med2005;201(9):1479–86.
16.
ChoiJHSuhCHLeeYMSuhYJLeeSKKimSS. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol2003;30(11):2422–7.
17.
WaiteJCSkokosD. Th17 response and inflammatory autoimmune diseases. Intl J Inflam2012;2012:819467 Epub 2011 Nov 15.
18.
KawashimaMYamamuraMTaniaiMYamauchiHTanimotoTKurimotoM. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum2001;44(3):550–60.
19.
ColafrancescoSPrioriRAlessandriCPerriconeCPendolinoMPicarelliG. IL-18 serum level in adult onset still's disease: A marker of disease activity. Intl J Inflam2012;2012:156890 Epub 2012 Jun 18.
20.
ChenDYChenYMChenHHHsiehCWLinCCLanJL. Functional association of interleukin 18 gene-607 (C/A) promoter polymorphisms with disease course in Chinese patients with adult-onset Still's disease. J Rheumatol2009;36(10):2284–9.
21.
RauMSchillerMKrienkeSHeyderPLorenzHBlankN. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis. J Rheumatol2010;37(11):2369–76.
22.
KomiyaAMatsuiTNogiSIwataKFutamiHTakaokaH. Neutrophil CD64 is upregulated in patients with active adult-onset Still's disease. Scand J Rheumatol2012;41(2):156–8.
23.
JungSYParkYBHaYJLeeKHLeeSK. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease. J Rheumatol2010;37(5):1029–34.
24.
ZouYQLuLJLiSJZengTWangXDBaoCD. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease. Clin Biochem2008;41(7–8):519–24.
25.
ChenDYLanJLLinFJHsiehTY. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease. Arthritis Rheum2005;53(3):320–7.
26.
MatsuiKTsuchidaTHiroishiKTominagaKHayashiNHadaT. High serum level of macrophage-colony stimulating factor (M-CSF) in adult-onset Still's disease. Rheumatology (Oxford)1999;38(5):477–8.
27.
CloughJD. Adult Still's disease and juvenile chronic polyarthritis. arthritis. Cleveland Clinic Pr; 2006. p. 189.
28.
OhtaAYamaguchiMTsunematsuTKasukawaRMizushimaHKashiwagiH. Adult Still's disease: A multicenter survey of Japanese patients. J Rheumatol1990;17(8):1058–63.
YamaguchiMOhtaATsunematsuTKasukawaRMizushimaYKashiwagiH. Preliminary criteria for classification of adult Still's disease. J Rheumatol1992;19(3):424–30.
31.
MokCCLauCSWongRW. Clinical characteristics, treatment, and outcome of adult onset Still's disease in southern Chinese. J Rheumatol1998;25(12):2345–51.
32.
OtaTHigashiSSuzukiHEtoS. Increased serum ferritin levels in adult Still's disease. Lancet1987;1(8532):562–3.
33.
Schwarz-EywillMHeiligBBauerHBreitbartAPezzuttoA. Evaluation of serum ferritin as a marker for adult Still's disease activity. Ann Rheum Dis1992;51(5):683–5.
34.
FautrelBLe MoëlGSaint-MarcouxBTaupinPVignesSRozenbergS. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol2001;28(2):322–9.
35.
LeeMHMeansRT. Extremely elevated serum ferritin levels in a university hospital: Associated diseases and clinical significance. Am J Med1995;98(6):566–71.
36.
JeonYKPaikJHParkSSParkSOKimYAKimJE. Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy. J Clin Pathol2004;57(10):1052–6.
37.
JiangLWangZDaiXJinX. Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population. J Rheumatol2011;38(4):741–6.
CushJJMedsgerTAChristyWCHerbertDCCoopersteinLA. Adult-onset Still's disease. Clinical course and outcome. Arthritis Rheum1987;30(2):186–94.
40.
ReginatoAJSchumacherHRBakerDGO'ConnorCRFerreirosJ. Adult onset Still's disease: Experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum1987;17(1):39–57.
41.
FautrelBZingEGolmardJLLe MoelGBisseryARiouxC. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore)2002;81(3):194–200.
42.
FautrelB. Adult-onset Still disease. Best Pract Res Clin Rheumatol2008;22(5):773–92.
43.
TacconeFSLucidiVDonckierVBourgeoisNDecauxGVandergheynstF. Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still's disease. Eur J Intern Med2008;19(6):e26–8.
44.
ArletJLeTMarinhoAAmouraZWechslerBPapoT. Reactive haemophagocytic syndrome in adult-onset Still's disease: A report of six patients and a review of the literature. Ann Rheum Dis2006;65(12):1596–601.
45.
AricòMJankaGFischerAHenterJIBlancheSElinderG. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia1996;10(2):197–203.
46.
HenterJIHorneAAricóMEgelerRMFilipovichAHImashukuS. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer2007;48(2):124–31.
47.
ImashukuS. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment. Int J Hematol1997;66(2):135–51.
48.
StephanJKone-PautIGalambrunC. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford)2001;40(11):1285–92.
49.
FukayaSYasudaSHashimotoTOkuKKataokaHHoritaT. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: Analysis of 30 cases. Rheumatology (Oxford)2008;47(11):1686–91.
50.
MouyRStephanJPilletPHaddadEHubertPPrieurA. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases. J Pediatr1996;129(5):750–4.
51.
YoshizakiAKawakamiAAramakiTIdaHEguchiK. Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still's disease presenting as agranulocytosis and hypercytokinemia. Clin Exp Rheumatol2008;26(2):383.
52.
EfthimiouP. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis2006;65(5):564–72.
53.
WoutersJMvan de PutteLB. Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med1986;61(235):1055–65.
54.
MitamuraMTadaYKoaradaSInoueHSuematsuROhtaA. Cyclosporin A treatment for Japanese patients with severe adult-onset Still's disease. Mod Rheumatol2009;19(1):57–63.
55.
MassonCLe LoëtXLiotéFRenouPDubostJJBoissierMC. Adult Still's disease. Part II. Management, outcome, and prognostic factors. Rev Rhum Engl Ed1995;62(11):758–65.
56.
FujiiTAkizukiMKamedaHMatsumuraMHirakataMYoshidaT. Methotrexate treatment in patients with adult onset Still's disease–retrospective study of 13 Japanese cases. Ann Rheum Dis1997;56(2):144–8.
57.
JungJHJunJBYooDHKimTHJungSSLeeIH. High toxicity of sulfasalazine in adult-onset Still's disease. Clin Exp Rheumatol2000;18(2):245–8.
58.
KomatsudaAOkamotoYHatakeyamaTWakuiHSawadaK. Sulfasalazine-induced hypersensitivity syndrome and hemophagocytic syndrome associated with reactivation of Epstein-Barr virus. Clin Rheumatol2008;27(3):395–7.
59.
Pérez-DePMiranda-CandónICamps-GarcíaMGómez-HuelgasR. [Hemophagocytic syndrome in adult Still disease after initiation of sulfasalazine]. Rev Clin Esp2010;210(5):251–2.
60.
BenucciMLiGDelRManfrediM. Adalimumab (anti-TNF-alpha) therapy to improve the clinical course of adult-onset Still's disease: The first case report. Clin Exp Rheumatol2005;23(5):733.
61.
FautrelBSibiliaJMarietteXCombeB, Club Rhumatismes et Inflammation. Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: An observational study of 20 cases. Ann Rheum Dis2005;64(2):262–6.
62.
LaskariKTzioufasAGMoutsopoulosHM. Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still's disease: A case-series study. Arthritis Res Ther2011;13(3):R91.
63.
OlgaAKontziasPPetrosE. Successful use of the IL1 trap rilonacept in adult-onset Still's disease refractory to anakinra. Ann Rheum Dis (supplement 3) 2011;70.
64.
KontziasAEfthimiouP. The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease. Semin Arthritis Rheum2012;42(2):201–5.
65.
YoshidaYSakamotoMYokotaKSatoKMimuraT. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease. Intern Med2011;50(16):1757–60.
66.
QuartuccioLMasetMDe VitaS. Efficacy of abatacept in a refractory case of adult-onset Still's disease. Clin Exp Rheumatol2010;28(2):265–7.
